TCM
PRCT icon

TimesSquare Capital Management’s Procept Biorobotics PRCT Stock Holding History

TimesSquare Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-48,737
Closed -$1.86M – 220
2021
Q3 		$1.86M Buy
+48,737
New +$1.87M 0.02% 208

Other funds holding PRCT

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TimesSquare Capital Management's PRCT Position: Q4 2021 in Review

TimesSquare Capital Management sold out of Procept Biorobotics (PRCT) in Q4 2021, closing a stake of 48,737 shares — an estimated $1.86M sold.

TimesSquare Capital Management first reported a position in PRCT in Q3 2021 and held it in 1 quarter. The position peaked at $1.86M in Q3 2021. 60 funds tracked by Wall St. Rank hold PRCT as of Q4 2021.

  • TimesSquare Capital Management reported no remaining Procept Biorobotics position as of Q4 2021 after selling out during the quarter.
  • TimesSquare Capital Management sold 48,737 Procept Biorobotics shares in Q4 2021, an estimated $1.86M.
  • TimesSquare Capital Management first reported a position in Procept Biorobotics in Q3 2021 and held it in 1 quarter.
  • TimesSquare Capital Management's Procept Biorobotics position peaked at $1.86M in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2021.

Based on TimesSquare Capital Management's 13F filing for Q4 2021, filed 4 Feb 2022.